Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

被引：0
|
作者：
Schwartz, G
Chu, QSC
Hammond, LA
Mita, M
Curtright, J
Versola, MJ
Koch, K
Pandite, LN
Ho, PTC
Rowinsky, EK
机构：
[1] Brooke Army Med Ctr, San Antonio, TX USA
[2] Inst Drug Dev, San Antonio, TX USA
[3] GlaxoSmithKline, Res Triangle Pk, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3070
引用
收藏
页码：212S / 212S
页数：1
相关论文
共 50 条
  • [31] Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors
    Simonelli, Matteo
    Zucali, Paolo A.
    Lorenzi, Elena
    Rubino, Luca
    De Vincenzo, Fabio
    De Sanctis, Rita
    Perrino, Matteo
    Mancini, Luca
    Di Tommaso, Luca
    Rimassa, Lorenza
    Masci, Giovanna
    Zuradelli, Monica
    Suter, Matteo B.
    Bertossi, Monica
    Fattuzzo, Giuseppe
    Giordano, Laura
    Roncalli, Massimo G.
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (05) : 989 - 998
  • [32] Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Townsley, C.
    Oza, A. M.
    Tang, P.
    Siu, L. L.
    Pond, G. R.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J. A.
    Chen, E. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Phase I study of ispinesib (SB-715992) in combination with capecitabine in patients with advanced solid tumors.
    Calvo, E
    Chu, Q
    Till, E
    Rowinsky, EK
    Patnaik, A
    Takimoto, C
    Kathman, SJ
    Williams, DD
    Bowen, CJ
    Hodge, JP
    Dar, MM
    Tolcher, AW
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9120S - 9120S
  • [34] Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors
    Verschraegen, C.
    Sweeney, C.
    Chiorean, G.
    Lee, F. C.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    EJC SUPPLEMENTS, 2007, 5 (04): : 111 - 111
  • [35] Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
    Paz-Ares, Luis
    Forster, Martin
    Boni, Valentina
    Szyldergemajn, Sergio
    Corral, Jesus
    Turnbull, Samantha
    Cubillo, Antonio
    Fernandez Teruel, Carlos
    Lopez Calderero, Iker
    Siguero, Mariano
    Bohan, Patrick
    Calvo, Emiliano
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 198 - 206
  • [36] Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
    Luis Paz-Ares
    Martin Forster
    Valentina Boni
    Sergio Szyldergemajn
    Jesús Corral
    Samantha Turnbull
    Antonio Cubillo
    Carlos Fernandez Teruel
    Iker López Calderero
    Mariano Siguero
    Patrick Bohan
    Emiliano Calvo
    Investigational New Drugs, 2017, 35 : 198 - 206
  • [37] A phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors
    Cassidy, J
    Dirix, L
    Bissett, D
    Reigner, B
    Griffin, T
    Allman, D
    Osterwalder, B
    Van Oosterom, AT
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2755 - 2761
  • [38] Phase I And pharmacokinetic (PK) study of irofulven (IROF) and capecitabine (CAP) in combination using an intermittent schedule in advanced solid tumors.
    Alexandre, J
    Bertheault-Cvitkovic, F
    Hilgers, W
    Shibata, S
    Raymond, E
    Taamma, K
    Misset, JL
    Weems, G
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6084S - 6084S
  • [39] Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors
    Couteau, C
    Risse, ML
    Ducreux, M
    Lefresne-Soulas, F
    Riva, A
    Lebecq, A
    Ruffié, P
    Rougier, P
    Lokiec, F
    Bruno, R
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3545 - 3552
  • [40] Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors
    Lee, Keun-Wook
    Lee, Dae Ho
    Kang, Jin Hyoung
    Park, Joon Oh
    Kim, Se Hyun
    Hong, Yong Sang
    Kim, Seung Tae
    Oh, Do-Youn
    Bang, Yung-Jue
    ONCOLOGIST, 2018, 23 (02): : 155 - +
12345